![Amy Moore: Proud to be serving as a mentor for the IASLC Academy for the third year](https://oncodaily.com/pub/uploads/2024/08/Screenshot-2024-08-23-02530111-e1724367373971.png)
Amy Moore: Proud to be serving as a mentor for the IASLC Academy for the third year
Amy Moore shared IASLC’s post on X, adding:
“I am proud to be serving as a mentor for the IASLC Academy for the third year. The future of thoracic oncology is strong with these rising leaders in lung cancer research and patient care. I look forward to hearing their presentations and celebrating their success at WCLC24!”
Quoting IASLC’s post about a recent paper by Erin Jungmeyer titled “2024 IASLC Academy to Once Again Compete in Amazing Case Race” published in IASLC Lung Cancer News.
Author: Erin Jungmeyer
“A friendly competition among the 2024 IASLC Academy class will culminate at WCLC24. Participants Sally Lau and Maria Gemelli share thoughts about the experience in ILCN.”
Source: Amy Moore/X and IASLC/X
Other posts featuring Amy Moore and IASLC on OncoDaily.
Dr. Amy C. Moore is the Vice President of Global Engagement and Patient Partnerships at LUNGevity Foundation. She previously served as the Director of Science & Research at the Addario Lung Cancer Medical Institute (ALCMI).
She has published peer-reviewed papers on virology, cancer, and biomarker testing in NSCLC. Dr. Moore is also an expert on COVID-19’s impact on lung cancer and serves on several advisory boards.